Acridine Orange

ADVERTISEMENT

Identification

Molecular formula
C26H31N3
CAS Number
6581-06-2
IUPAC Name
9,9-dimethyl-10-[3-[4-(4-methylpiperazin-1-yl)-1-piperidyl]propyl]acridine
Molecular Weight
393.55g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2790g/cm3
Interesting facts

Interesting Facts about 9,9-Dimethyl-10-[3-[4-(4-methylpiperazin-1-yl)-1-piperidyl]propyl]acridine

This complex compound, a derivative of acridine, has garnered attention in the fields of medicinal chemistry and pharmacology due to its intriguing structure and potential applications. Here are some notable insights:

  • Pharmacological Potential: The unique structure of this compound suggests potential activity in the treatment of various neurological disorders. Compounds with acridine moieties have shown promise as antipsychotic and antidepressant agents.
  • Structure-Activity Relationship (SAR): The incorporation of piperazine and piperidine rings within the compound plays a crucial role in enhancing its biological properties. These rings are known for their ability to interact with various neurotransmitter receptors, which can modulate neurochemical pathways.
  • Research Significance: This compound serves as a valuable lead in drug discovery, particularly for developing new therapeutics targeting central nervous system (CNS) disorders. Researchers are continuously investigating its potential effects on mood and cognition.
  • Versatile Design: The dimethyl substitution at the acridine core not only contributes to the overall lipophilicity of the compound but also affects its binding affinity to molecular targets.

As with many compounds of this complexity, the ongoing research is crucial for uncovering its full potential, and future studies will surely elaborate on its mechanisms of action and therapeutic uses.

In the world of chemistry, compounds like this exemplify the exquisite interplay of molecular architecture and biological function, reminding us of the continued importance of structural design in rational drug development.

ADVERTISEMENT